Impact of Propeptide Cleavage on the Stability and Activity of a Streptococcal Immunomodulatory C5a Peptidase for Biopharmaceutical Development.
Authors
Gedi, VinayakumarDuarte, Francisco
Patel, Pratikkumar
Bhattacharjee, Promita
Tecza, Malgorzata
McGourty, Kieran
Hudson, Sarah P
Issue Date
2023-07-05Keywords
C5a peptidasebiopharmaceutical
propeptide cleavage
protein purification
protein stability
Metadata
Show full item recordJournal
Molecular pharmaceuticsDOI
10.1021/acs.molpharmaceut.3c00207PubMed ID
37406301Item Type
ArticleOther
Language
enEISSN
1543-8392ae974a485f413a2113503eed53cd6c53
10.1021/acs.molpharmaceut.3c00207
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Related articles
- Model for substrate interactions in C5a peptidase from Streptococcus pyogenes: A 1.9 A crystal structure of the active form of ScpA.
- Authors: Kagawa TF, O'Connell MR, Mouat P, Paoli M, O'Toole PW, Cooney JC
- Issue date: 2009 Feb 27
- Streptococcal C5a peptidase is a highly specific endopeptidase.
- Authors: Cleary PP, Prahbu U, Dale JB, Wexler DE, Handley J
- Issue date: 1992 Dec
- C5a peptidase (ScpA) activity towards human type II and type III interferons.
- Authors: Duarte F, Teçza M, Gedi V, McGourty K, Hudson SP
- Issue date: 2024 Aug
- Processing, stability, and kinetic parameters of C5a peptidase from Streptococcus pyogenes.
- Authors: Anderson ET, Wetherell MG, Winter LA, Olmsted SB, Cleary PP, Matsuka YV
- Issue date: 2002 Oct
- Multi-functional mechanisms of immune evasion by the streptococcal complement inhibitor C5a peptidase.
- Authors: Lynskey NN, Reglinski M, Calay D, Siggins MK, Mason JC, Botto M, Sriskandan S
- Issue date: 2017 Aug